Lexington Biosciences Announces Appointment of CEO
16 avr. 2020 18h29 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 16, 2020 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) is pleased to announce the appointment of Donald McInnes as...
Lexington Biosciences Provides Corporate Update
20 févr. 2020 14h16 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) provides the following corporate update to shareholders. ...
Lexington Biosciences License Terminated
12 févr. 2020 21h13 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) has allowed the license with the Lawrence Berkeley National...
Lexington Biosciences Converts Amounts Owed to Unsecured Demand Loans
04 oct. 2019 15h28 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) announces that it has reached agreement with third parties as...
Lexington Biosciences to Consolidate its Common Shares
25 avr. 2019 08h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 25, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces that effective at the opening of...
Lexington Biosciences Provides Update on Financial Situation
02 avr. 2019 04h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announced on February 14, 2019 that it had been...
Lexington Biosciences Announces Termination of Private Placement
14 févr. 2019 17h05 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces that, despite numerous attempts over the...
Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement
29 nov. 2018 23h46 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces the release of the Company’s Condensed...
Lexington Provides Q3 Corporate Review
23 oct. 2018 18h37 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Announces Non-Brokered Private Placement
27 août 2018 09h00 HE
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27,...